Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 71

1.

2-Hydroxy-N-phenylbenzamides and Their Esters Inhibit Acetylcholinesterase and Butyrylcholinesterase.

Krátký M, Štěpánková Š, Houngbedji NH, Vosátka R, Vorčáková K, Vinšová J.

Biomolecules. 2019 Nov 5;9(11). pii: E698. doi: 10.3390/biom9110698.

2.

Phenolic N-monosubstituted carbamates: Antitubercular and toxicity evaluation of multi-targeting compounds.

Krátký M, Janďourek O, Baranyai Z, Novotná E, Stolaříková J, Bősze S, Vinšová J.

Eur J Med Chem. 2019 Nov 1;181:111578. doi: 10.1016/j.ejmech.2019.111578. Epub 2019 Aug 1.

PMID:
31401536
3.

Design, synthesis and antimycobacterial activity of hybrid molecules combining pyrazinamide with a 4-phenylthiazol-2-amine scaffold.

Zitko J, Jand'ourek O, Paterová P, Navrátilová L, Kuneš J, Vinšová J, Doležal M.

Medchemcomm. 2018 Feb 22;9(4):685-696. doi: 10.1039/c8md00056e. eCollection 2018 Apr 1.

4.

Investigation of salicylanilide and 4-chlorophenol-based N-monosubstituted carbamates as potential inhibitors of acetyl- and butyrylcholinesterase.

Krátký M, Štěpánková Š, Vorčáková K, Vinšová J.

Bioorg Chem. 2018 Oct;80:668-673. doi: 10.1016/j.bioorg.2018.07.017. Epub 2018 Jul 17.

PMID:
30059892
5.

In vitro activity of salicylamide derivatives against vancomycin-resistant enterococci.

Pospisilova S, Michnova H, Kauerova T, Pauk K, Kollar P, Vinsova J, Imramovsky A, Cizek A, Jampilek J.

Bioorg Med Chem Lett. 2018 Jul 1;28(12):2184-2188. doi: 10.1016/j.bmcl.2018.05.011. Epub 2018 May 14.

PMID:
29773506
6.

New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action.

Vosátka R, Krátký M, Švarcová M, Janoušek J, Stolaříková J, Madacki J, Huszár S, Mikušová K, Korduláková J, Trejtnar F, Vinšová J.

Eur J Med Chem. 2018 May 10;151:824-835. doi: 10.1016/j.ejmech.2018.04.017. Epub 2018 Apr 10.

PMID:
29679902
7.

Triclosan and its derivatives as antimycobacterial active agents.

Vosátka R, Krátký M, Vinšová J.

Eur J Pharm Sci. 2018 Mar 1;114:318-331. doi: 10.1016/j.ejps.2017.12.013. Epub 2017 Dec 23. Review.

PMID:
29277667
8.

Synthesis and biological evolution of hydrazones derived from 4-(trifluoromethyl)benzohydrazide.

Krátký M, Bősze S, Baranyai Z, Stolaříková J, Vinšová J.

Bioorg Med Chem Lett. 2017 Dec 1;27(23):5185-5189. doi: 10.1016/j.bmcl.2017.10.050. Epub 2017 Oct 21.

PMID:
29097168
9.

Sulfadiazine Salicylaldehyde-Based Schiff Bases: Synthesis, Antimicrobial Activity and Cytotoxicity.

Krátký M, Dzurková M, Janoušek J, Konečná K, Trejtnar F, Stolaříková J, Vinšová J.

Molecules. 2017 Sep 19;22(9). pii: E1573. doi: 10.3390/molecules22091573.

10.

In vitro biological evaluation of new antimycobacterial salicylanilide-tuftsin conjugates.

Baranyai Z, Krátký M, Vosátka R, Szabó E, Senoner Z, Dávid S, Stolaříková J, Vinšová J, Bősze S.

Eur J Med Chem. 2017 Jun 16;133:152-173. doi: 10.1016/j.ejmech.2017.03.047. Epub 2017 Mar 24.

PMID:
28384546
11.

Novel Sulfamethoxazole Ureas and Oxalamide as Potential Antimycobacterial Agents.

Krátký M, Stolaříková J, Vinšová J.

Molecules. 2017 Mar 28;22(4). pii: E535. doi: 10.3390/molecules22040535.

12.

Corrigendum to "Novel salicylanilides from 4,5-dihalogenated salicylic acids: Synthesis, antimicrobial activity and cytotoxicity" [Bioorg. Med. Chem. 25 (2017) 1524-1532].

Paraskevopoulos G, Monteiro S, Vosátka R, Krátký M, Navrátilová L, Trejtnar F, Stolaříková J, Vinšová J.

Bioorg Med Chem. 2017 Apr 15;25(8):2530. doi: 10.1016/j.bmc.2017.02.053. Epub 2017 Mar 10. No abstract available.

PMID:
28285926
13.

Synthesis of readily available fluorophenylalanine derivatives and investigation of their biological activity.

Krátký M, Štěpánková Š, Vorčáková K, Navrátilová L, Trejtnar F, Stolaříková J, Vinšová J.

Bioorg Chem. 2017 Apr;71:244-256. doi: 10.1016/j.bioorg.2017.02.010. Epub 2017 Feb 21.

PMID:
28245905
14.

Antimicrobial activity of rhodanine-3-acetic acid derivatives.

Krátký M, Vinšová J, Stolaříková J.

Bioorg Med Chem. 2017 Mar 15;25(6):1839-1845. doi: 10.1016/j.bmc.2017.01.045. Epub 2017 Feb 1.

PMID:
28196707
15.

Novel salicylanilides from 4,5-dihalogenated salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.

Paraskevopoulos G, Monteiro S, Vosátka R, Krátký M, Navrátilová L, Trejtnar F, Stolaříková J, Vinšová J.

Bioorg Med Chem. 2017 Feb 15;25(4):1524-1532. doi: 10.1016/j.bmc.2017.01.016. Epub 2017 Jan 14. Erratum in: Bioorg Med Chem. 2017 Apr 15;25(8):2530.

PMID:
28126437
16.

Synthesis and in vitro evaluation of novel rhodanine derivatives as potential cholinesterase inhibitors.

Krátký M, Štěpánková Š, Vorčáková K, Vinšová J.

Bioorg Chem. 2016 Oct;68:23-9. doi: 10.1016/j.bioorg.2016.07.004. Epub 2016 Jul 6.

PMID:
27428597
17.
18.

Salicylanilide N-monosubstituted carbamates: Synthesis and in vitro antimicrobial activity.

Krátký M, Vinšová J.

Bioorg Med Chem. 2016 Mar 15;24(6):1322-30. doi: 10.1016/j.bmc.2016.02.004. Epub 2016 Feb 4.

PMID:
26879856
19.

Novel Cholinesterase Inhibitors Based on O-Aromatic N,N-Disubstituted Carbamates and Thiocarbamates.

Krátký M, Štěpánková Š, Vorčáková K, Švarcová M, Vinšová J.

Molecules. 2016 Feb 11;21(2). pii: E191. doi: 10.3390/molecules21020191.

20.

Synthesis of triclosan derivatives and their antimycobacterial effect.

Vosátka R, Krátký M, Vinšová J.

Ceska Slov Farm. Fall 2014;63(6):302. No abstract available.

PMID:
26837886

Supplemental Content

Loading ...
Support Center